Open AccessReal-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey
Author(s) -
Matthew J. Pingree,
Mark Fb Hurdle,
David Spinner,
Ali Valimahomed,
Nathan D. Crosby,
Joseph W. Boggs
Publication year - 2022
Publication title -
pain management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.402
H-Index - 21
eISSN - 1758-1877
pISSN - 1758-1869
DOI - 10.2217/pmt-2022-0005
Subject(s) - medicine , quality of life (healthcare) , cross sectional study , peripheral nerve stimulation , physical therapy , pain relief , chronic pain , peripheral , stimulation , anesthesia , nursing , pathology
Objective: This study presents real-world data from a cross-sectional follow-up survey of patients who previously received 60-day peripheral nerve stimulation (PNS) treatment for pain. Materials & methods: A survey including validated pain and other related outcome measures was distributed to patients who previously underwent implantation of temporary PNS leads for 60-day PNS treatment. Results: Among survey respondents who were at least 3 months from the start of treatment, most reported sustained clinically significant improvements in pain and/or quality of life, with the length of follow-up at the time of survey completion ranging from 3 to 30 months. Conclusion: These real-world data support recent prospective studies indicating that 60-day percutaneous PNS provides significant and sustained relief across a wide range of pain conditions.